Merck & Company, Inc. News Headlines

MRK 
$59.58
*  
0.60
1.02%
Get MRK Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Strong Portfolio, Dividends Make Merck An Attractive Opportunity
12/8/2014 3:40:00 PM - Seeking Alpha


Why Jim Cramer Likes Merck's (MRK) Acquisition of Cubist Pharmaceuticals (CBST)
12/8/2014 3:17:00 PM - TheStreet


Assessing The Magnitude Of Pfizer's Coming Dividend Increase
12/8/2014 3:11:00 PM - Seeking Alpha


Merck's New Oncology Product Positive in Early Study - Analyst Blog
12/8/2014 3:10:00 PM - Zacks.com


Merck Seeks Growth Injection, Picks Off Antibiotic Maker Cubist
12/8/2014 2:56:00 PM - TheStreet


Health Care Sector Update for 12/08/2014: BLRX,CBST,MRK,ALR
12/8/2014 1:34:43 PM - MT Newswires


Midday Update: Global Growth Worries Weigh on Equities; Oil Stocks Resume Slide as Crude Again Stumbles
12/8/2014 12:46:22 PM - MT Newswires


European Stocks Slide As ECB''s Nowotny Warns On Deflation
12/8/2014 12:14:00 PM - RTT News


Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 3rd Update
12/8/2014 12:11:00 PM - Dow Jones Business News


Why Shares of Cubist Pharmaceuticals Inc Skyrocketed
12/8/2014 11:51:02 AM - Motley Fool


U.S. Stocks Down
12/8/2014 11:42:00 AM - Dow Jones Business News


VTV, MRK, BMY, UNH: Large Outflows Detected at ETF
12/8/2014 11:22:09 AM - BNK Invest


Correction to U.S. Stocks Story
12/8/2014 10:49:00 AM - Dow Jones Business News


U.S. Stocks Edge Lower
12/8/2014 10:38:00 AM - Dow Jones Business News


Today's Market: Mergers And Acquisitions, Content Deals And Analyst Moves
12/8/2014 9:57:00 AM - Seeking Alpha


Correction to Merck-Cubist Deal Story
12/8/2014 9:57:00 AM - Dow Jones Business News


Merck Aims at Superbugs with $9.5B Cubist Buy
12/8/2014 9:42:00 AM - Fox Business


Cubist Pharmaceuticals Inc. (CBST) Has Soared To A New High After Merck Buys
12/8/2014 9:33:00 AM - RTT News


A Comprehensive Comparison Of Gilead's Harvoni And AbbVie's Triple HCV Regimen: What The HCV Marketplace May Look Like In 2015 And Beyond
12/8/2014 9:23:00 AM - Seeking Alpha


Futures Lower As Global Growth Concerns Triggered Overseas
12/8/2014 9:18:00 AM - MT Newswires


Merck To Buy Cubist Pharma For $8.4 Bln
12/8/2014 9:05:00 AM - RTT News


MARKET SNAPSHOT: U.S. Stocks: Futures Fall As Global Growth Concerns Resurface
12/8/2014 8:56:00 AM - Dow Jones Business News


Health Care Sector Update for 12/08/2014: ARIA, AGIO, ADXS, KND
12/8/2014 8:24:59 AM - MT Newswires


Time to Buy This Dip in Gilead Sciences, Inc. Stock?
12/8/2014 8:07:02 AM - Motley Fool


Merck Acquisition Conference Call At 8:00 AM ET
12/8/2014 7:30:00 AM - RTT News